New hope for patients with rare, deadly lung complication
NCT ID NCT07473700
Summary
This study is testing a new drug called TX000045 for people who have high blood pressure in their lungs (pulmonary hypertension) caused by underlying scarred lung tissue (interstitial lung disease). The main goals are to see if the drug reduces the resistance to blood flow in the lungs and to check how safe it is over 16 weeks. It will involve about 25 participants who are not yet on other specific medications for this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION, PULMONARY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Barcelona
Barcelona, 08002, Spain
-
Belgrade
Belgrade, 11000, Serbia
-
Bucharest
Bucharest, 022328, Romania
-
Krakow
Krakow, 31-202, Poland
-
Niš
Niš, 18000, Serbia
-
Scottsdale, Arizona
Scottsdale, Arizona, 85258, United States
Conditions
Explore the condition pages connected to this study.